Search

Indication:Baricitinib is indicated for the treatment of adult patients with moderately to severely active Rheumatoid Arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.Dosage & Administration:The recommended dose of Baricitinib is 2 mg once..